For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230301:nRSA4214Ra&default-theme=true
RNS Number : 4214R Plant Health Care PLC 01 March 2023
Plant Health Care plc
("Plant Health Care" or "the Company")
Director Dealings / PDMR Shareholding
Plant Health Care, a leading provider of novel patent-protected biological
products to global agricultural markets, has been informed that on 27 February
2023, Dr Christopher Richards, Chairman of the Company, transferred 1,487,958
ordinary shares of 0.01 pence each in the capital of the Company ("Ordinary
Shares") held by him to an ISA held in the name of him and his wife. This
transfer was effected by the sale of 1,487,958 Ordinary Shares at a price of
£0.10402 pence per Ordinary Share and the immediate repurchase of 1,487,958
Ordinary Shares at a price of £0.104 per Ordinary Share.
Following this transfer, the total number of Ordinary Shares held by Dr
Richards and persons closely associated with him is unchanged and those
parties are beneficially interested in 4,285,527 Ordinary Shares, representing
approximately 1.4% of the Company's issued share capital.
Enquiries
Plant Health Care plc +1 919 926 1600
Jeff Tweedy - CEO
Cenkos Securities plc - Nomad & Broker +44 (0) 131 220 9771
Neil McDonald / Peter Lynch
Company website: www.planthealthcare.com (http://www.planthealthcare.com)
The information set out below is provided in accordance with the requirements
of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Dr Christopher Richards
2 Reason for the notification
a) Position/status Chairman
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Plant Health Care plc
b) LEI
213800KBQPJZ2FM8QH27
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 1p each
GB00B01JC540
Identification code
b) Nature of the transaction 1. Sale of Shares
2. Sale of Shares
3. Purchase of Ordinary Shares
4. Purchase of Ordinary Shares
c) Price(s) and volume(s) Price(s) Volume(s)
1. £0.10402 542,000
2. £0.10402 945,958
3. £0.104 542,000
4. £0.104 945,958
d) Aggregated information
- Aggregated volume
- Sale of Ordinary Shares: 1,487,958
Purchase of Ordinary Shares: 1,487,958
Price
Sale of Ordinary Shares: £0.10402
Purchase of Ordinary Shares: £0.104
e) Date of the transaction 27.02.2023
f) Place of the transaction AIM, London Stock Exchange
d)
Aggregated information
- Aggregated volume
-
Price
Sale of Ordinary Shares: 1,487,958
Purchase of Ordinary Shares: 1,487,958
Sale of Ordinary Shares: £0.10402
Purchase of Ordinary Shares: £0.104
e)
Date of the transaction
27.02.2023
f)
Place of the transaction
AIM, London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHSEDEEAEDSEFE